(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.81%) $83.17
(-1.16%) $1.619
(-0.39%) $2 338.10
(0.02%) $27.54
(0.70%) $928.60
(-0.16%) $0.933
(-0.12%) $11.01
(-0.22%) $0.799
(0.00%) $92.17
-5.26% $ 1.260
Live Chart Being Loaded With Signals
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease...
Stats | |
---|---|
Dzisiejszy wolumen | 28 089.00 |
Średni wolumen | 100 379 |
Kapitalizacja rynkowa | 36.18M |
EPS | $0 ( 2024-03-18 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.020 |
ATR14 | $0.0120 (0.95%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Sieger Markus | Buy | 14 004 | Common Stock |
2024-02-13 | Ostronic Francis Patrick | Buy | 8 703 | Common Stock |
2024-02-13 | Toig Randall M. | Buy | 7 516 | Common Stock |
2024-02-13 | Strattan Ce Rick | Buy | 6 963 | Common Stock |
2024-02-13 | Wong Vivien | Buy | 6 330 | Common Stock |
INSIDER POWER |
---|
50.71 |
Last 99 transactions |
Buy: 16 269 213 | Sell: 5 479 045 |
Cyclo Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
STRO | 0.944 |
ASPU | 0.94 |
LSXMK | 0.922 |
LSXMA | 0.922 |
PRTG | 0.917 |
NAKD | 0.917 |
BOCH | 0.915 |
SIRI | 0.911 |
ACRX | 0.91 |
BFRI | 0.91 |
10 Najbardziej negatywne korelacje | |
---|---|
PAE | -0.928 |
RMRM | -0.927 |
APOP | -0.916 |
PESI | -0.907 |
EBSB | -0.905 |
INTA | -0.905 |
LMNR | -0.905 |
NCAC | -0.903 |
NVDA | -0.903 |
FTNT | -0.902 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cyclo Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $1.08M |
Zysk brutto: | $-2.41M (-223.91 %) |
EPS: | $-1.230 |
FY | 2023 |
Przychody: | $1.08M |
Zysk brutto: | $-2.41M (-223.91 %) |
EPS: | $-1.230 |
FY | 2022 |
Przychody: | $1.38M |
Zysk brutto: | $1.24M (89.90 %) |
EPS: | $-1.810 |
FY | 2021 |
Przychody: | $1.59M |
Zysk brutto: | $1.43M (90.16 %) |
EPS: | $-2.24 |
Financial Reports:
No articles found.
Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej